InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Discover the detailed record of transactions filed by GOLDSMITH MARK A, Dirigeant. Director active across 2 companies, notably Revolution Medicines, Inc.. In total, 12 filings have been published. Total volume traded: €247k. The latest transaction was filed on 17 March 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
€17,2771,023 shares@ €16.88826.2% of flow
Common Stock
SEC:0001567619-22-007324:0·
0104,000 shares0
Common Stock
SEC:0001567619-22-006237:0·
€33,8341,571 shares@ €21.536725.8% of flow
Common Stock
SEC:0001567619-21-022400·
€33,8341,571 shares@ €21.536712.1% of flow
Common Stock
SEC:0001567619-21-022400:0·
€16,35037,721 shares@ €0.433412.5% of flow
Common Stock
SEC:0001567619-21-021768·
€16,35037,721 shares@ €0.43345.8% of flow
Common Stock
SEC:0001567619-21-021768:0·
€39,0571,531 shares@ €25.51129.8% of flow
Common Stock
SEC:0001567619-21-017414·
€39,0571,531 shares@ €25.51114.0% of flow
Common Stock
SEC:0001567619-21-017414:0·
89,857 shares
Common Stock
SEC:0001562180-21-004981·
89,857 shares
Common Stock
SEC:0001562180-21-004981:0·
€41,9701,465 shares@ €28.648432.0% of flow
Common Stock
SEC:0001567619-21-012488·
€41,9701,465 shares@ €28.648415.0% of flow
Common Stock
SEC:0001567619-21-012488:0·
12 of 12 declarations
About GOLDSMITH MARK A
Mark A. Goldsmith is involved with Revolution Medicines, Inc. and CONSTELLATION PHARMACEUTICALS INC. His role involves overseeing operations and contributing to the strategy of these companies.
